Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 4:30 pm Purchase | 2024-12-31 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | BERNS PAUL L | 8,226,272 5.100% | 242,125 (+3.03%) | Filing History |
| 2024-11-22 5:33 pm Purchase | 2024-11-12 | 13D | Neumora Therapeutics, Inc. Common Stock NMRA | ARCH Venture Fund XII, L.P. | 31,979,111 19.800% | 12,904 (+0.04%) | Filing History |
| 2024-11-12 4:30 pm Sale | 2024-09-30 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | SoftBank Group Corp. | 7,546,916 4.700% | -100,000 (-1.31%) | Filing History |
| 2024-07-08 4:15 pm Unchanged | 2024-06-28 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | FMR LLC | 8,622,468 5.400% | 0 (Unchanged) | Filing History |
| 2024-07-08 1:07 pm Purchase | 2024-06-28 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | FMR LLC | 8,622,468 5.400% | 8,622,468 (New Position) | Filing History |
| 2024-02-14 4:17 pm Purchase | 2023-12-31 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | BERNS PAUL L | 7,984,147 5.200% | 7,984,147 (New Position) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-31 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | SoftBank Group Corp. | 7,646,916 5.000% | 7,646,916 (New Position) | Filing History |
| 2023-12-15 5:06 pm Purchase | 2023-12-08 | 13D | Neumora Therapeutics, Inc. Common Stock NMRA | ARCH Venture Fund XII, L.P. | 31,966,207 20.900% | 2,168,831 (+7.28%) | Filing History |
| 2023-09-29 8:22 pm Purchase | 2023-09-19 | 13D | Neumora Therapeutics, Inc. Common Stock NMRA | ARCH Venture Fund XII, L.P. | 29,797,376 19.600% | 29,797,376 (New Position) | Filing History |
| 2023-09-27 07:30 am Purchase | 2023-09-19 | 13D | Neumora Therapeutics, Inc. Common Stock NMRA | AMGEN INC AMGN | 35,368,653 23.200% | 35,368,653 (New Position) | Filing History |